Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 8, Pages 1854-1869Publisher
WILEY
DOI: 10.1111/bph.12394
Keywords
Alzheimer's disease; cancer; glycolysis; law of mass action; mitochondria; neurodegeneration
Categories
Funding
- University of Kansas Alzheimer's Disease Center [P30-AG035982]
- Frank and Evangeline Thompson Alzheimer's Treatment Development Fund
Ask authors/readers for more resources
Here we discuss a specific therapeutic strategy we call bioenergetic medicine'. Bioenergetic medicine refers to the manipulation of bioenergetic fluxes to positively affect health. Bioenergetic medicine approaches rely heavily on the law of mass action, and impact systems that monitor and respond to the manipulated flux. Since classically defined energy metabolism pathways intersect and intertwine, targeting one flux also tends to change other fluxes, which complicates treatment design. Such indirect effects, fortunately, are to some extent predictable, and from a therapeutic perspective may also be desirable. Bioenergetic medicine-based interventions already exist for some diseases, and because bioenergetic medicine interventions are presently feasible, new approaches to treat certain conditions, including some neurodegenerative conditions and cancers, are beginning to transition from the laboratory to the clinic. Linked ArticlesThis article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available